Diagnosis and treatment of orphan disease — homocystinuria and megaloblastic anemia, type cblG

The term «homocystinuria» combines a number of genetically determined nosological forms caused by defects of the metabolism of sulfur-containing amino acids (methionine, homocysteine), cobalamin and folate. The group of these diseases includes «classical» homocystinuria caused by insufficiency of cystathionine beta-synthase and forms associated with defects in methionine remethylation processes. More information is given about one of these forms — homocystinuria and megaloblastic anemia, type cblG, caused by MTR gene mutations. The results of observation of a child with this disease are presented. The clinical status includes: intellectual disability, autistic behavioral traits, stereotypes, nystagmus, visual impairment, macrocytic anemia, epilepsy in remission. Effective treatment requires the use of medications not registered in the Russian Federation — betaine and hydroxocobalamin.

1. Waters D., Adeloye D., Woolham D., Wastnedge E., Patel S., Rudan I. Global birth prevalence and mortality from inborn errors of metabolism: a systematic analysis of the evidence. J Glob Health 2018; 8(2): 021102. DOI: 10.7189/jogh.08.021102

2. Delanne J., Bruel A.L., Huet F., Moutton S., Nambot S., Grisval M. et al. The diagnostic rate of inherited metabolic disorders by exome sequencing in a cohort of 547 individuals with developmental disorders. Mol Genet Metab Rep 2021; 29: 100812. DOI: 10.1016/j.ymgmr.2021.100812

3. Huemer M., Diodato D., Schwahn B. Schiff M., Bandeira A., Benoist J.-F. et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disordes cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis 2017; 40(1): 21–48. DOI: 10.1007/s10545–016–9991–4

4. Semyachkina A.N., Voskoboeva E.Yu., Voinova V.Yu, Kurbatov M.B., Novikova I.M., Zakharova E.Yu., Novikov P.V. Clinical and genetic aspects and pathogenetic mechanisms of classical homocystinuria in children. Rossiyskiy vestnik perinatologii i pediatrii 2013; 58(3): 30–37. (in Russ.)

5. Semyachkina A., Voskoboeva E., Yablonskya M., Nikolaeva E. Clinical and Molecular Characteristics of Russian Patients with Homocystinuria due to Cystathionine Beta-Synthase Deficiency. J Neurol Neurophysiol 2018; 9: 458. DOI: 10.4172/2155–9562.1000458

6. Morris A.A.M., Kožich V., Santra S., Generoso A., Ben-Omran T.I.M., Chakrapani A.B. et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis 2017; 40: 49–74. DOI: 10.1007/S10545–016–9979–0

7. Almannai M., Marom R., Divin K., Scaglia F., Sutton V.R., Craigen W.J. et al. Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening. Mol Genet Metab 2017; 122(1–2): 60–66. DOI: 10.1016/j.ymgme.2017.06.011

8. Sloan J.L., Carrillo N., Adams D., Venditti C.P. Disorders of Intracellular Cobalamin Metabolism. In: Adam MP, Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Mirzaa G., Amemiya A., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2021. https:// www.ncbi.nlm.nih.gov/books/NBK1328/ Ссылка активна на 8.02.2023.

9. Hill K.P., Lukonis C.J., Korson M.S., Weinstein C., Thall M., Schwartz J.T. Neuropsychiatric illness in a patient with cobalamin G disease, an inherited disorder of vitamin B12 metabolism. Harv Rev Psychiatr 2004; 12: 116–122. DOI: 10.1080/10673220490447227

10. Keller R., Chrastina P., Pavlíková M., Gouveia S., Ribes A., Kölker S. et al. Newborn screening for homocystinurias: Recent recommendations versus current practice. J Inherit Metab Dis 2019; 42(1): 128–139. DOI: 10.1002/jimd.12034